Claritev Corporation

Claritev Corporation

CTEV

Get informed when a big investor buys or sells

+ Follow
Market Cap$532.57M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Claritev CorporationClaritev Corporation-1.8-119%0.5-19.1
$44.50

Target Price by Analysts

56.9% upsideClaritev Target Price DetailsTarget Price
$-48.24

Current Fair Value

270.1% downside

Overvalued by 270.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$532.57 Million
Enterprise Value$5.12 Billion
Dividend Yield$- (-)
Earnings per Share$-17.3
Beta0.7
Outstanding Shares16,692,340

Return

Return on Equity118.82%ROE
Return on Assets-5.92%
Return on Invested Capital-0.29%

Valuation & Multiples

P/E Ratio-1.8P/E Ratio
PEG-57.37PEG
Price to Sales0.49Price to Sales
Price to Book Ratio-1.89Price to Book Ratio
Enterprise Value to Revenue5.23
Enterprise Value to EBIT-382.22
Enterprise Value to Net Income-18
Total Debt to Enterprise0.9
Debt to Equity-19.11Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 14, 2026
EPS Estimate
$-2.26
Average shareholder expectation
Revenue Estimate
$238.59 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 5, 2026
EPS Estimate
$-4.10
Average shareholder expectation
Revenue Estimate
$244.81 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.5436 25.54%
Total Calls67,700 34.53%
Total Puts36,800 23.49%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %86.12% 0.62%
Total Invested$231.48M 61.58%
Investors Holding99 11.00%

ESG Score

No data

About Claritev Corporation

2,700 employees
CEO: Mr. Travis S. Dalton

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-...